Marrone bio innovations issues shareholder letter and provides operational update

Davis, calif., oct. 19, 2020 (globe newswire) -- marrone bio innovations, inc. (nasdaq: mbii) (“marrone bio”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, today released a letter to shareholders from chief executive officer, kevin helash.
MBII Ratings Summary
MBII Quant Ranking